Myositis Therapeutics Market Report 2024: Comprehensive Insights about 18+ Companies and 20+ Pipeline Drugs
18. Dezember 2024 09:37 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myositis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Idiopathic Inflammatory Myositis Industry Assessment, 2020-2034: Breakthrough Therapies (Dazukibart and Efgartigimod) Propel Market Expansion Across the 7MM
11. Dezember 2024 07:01 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Forecast to 2034" report has been added to ResearchAndMarkets.com's offering. ...
Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
13. November 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...